Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

After Negative FDA Committee Vote, Jazz Has Few Notes To Play Beyond Fibromyalgia

This article was originally published in The Pink Sheet Daily

Executive Summary

Jazz's reformulation of sodium oxybate for fibromyalgia ran into advisory committee skepticism last week, but at least one analyst predicts FDA will override the 20-2 negative vote.

You may also be interested in...



Freed From Pfizer, Capsugel May Find More Market Opportunities

Pfizer's divestiture of Capsugel moves the gelatin capsule manufacturer out from under pharma ownership, potentially opening a door to more business.

Freed From Pfizer, Capsugel May Find More Market Opportunities

Pfizer's divestiture of Capsugel moves the gelatin capsule manufacturer out from under pharma ownership, potentially opening a door to more business.

Freed From Pfizer, Capsugel May Find More Market Opportunities

Deal heightens attention Pfizer is attracting from the investment community, already anticipating divestments outside the firm's innovative core pharma business.

Related Content

Topics

UsernamePublicRestriction

Register

PS071073

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel